ArticleClinical ophthalmology (Auckland, N.Z.)2012

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections.

Bruce E Silverstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.